bioRxiv Science⌕ Search

Biology subjects

Soloff, A.

Publications and source records attributed to Soloff, A..

2 recordsLinked to original sources

A compact three-way junction oligonucleotide probe for widefield and super-resolution imaging of RNAs and proteins

Molecular imaging of RNAs and proteins requires methods that preserve nanoscale organization while enabling large-scale tissue analysis. However, weak or low-abundance targets often need signal amplification, which can increase labeling size, background, or signal spread and compromise super-resolution imaging. Here, we report a compact three-way junction (3WJ) oligonucleotide probe platform for multiscale RNA and protein imaging. The design couples paired target recognition with junction assembly and recruitment of preassembled amplifier complexes, while tunable amplification balances signal strength and labeling size. Using DNA origami and single-molecule localization microscopy, we show enhanced signal while retaining the ability to resolve nanoscale target patterns. The platform improves RNA detection and supports simultaneous RNA-protein super-resolution imaging in cells. It also enhances protein detection in formalin-fixed, paraffin-embedded tissues under low-numerical-aperture, large-field imaging conditions. Together, this programmable 3WJ platform enables sensitive RNA and protein detection across scales, supporting super-resolution analysis of molecular organization and large-field tissue mapping.

bioengineering↗

Integrative multi-omic analysis identifies tumor-intrinsic p38 as a driver of immune exclusion in human epithelial cancers

Patients with tumors not responding to immune-checkpoint inhibition (ICI) often harbor a non-T cell-inflamed tumor microenvironment, characterized by the absence of IFN-{gamma}-associated CD8+ T cells and dendritic cell activation. While the role of p38 mitogen-activated protein kinases (MAPKs) in regulating dendritic and myeloid cells is established, the tumor-intrinsic immunomodulatory function of p38 remains underexplored. Here, we identify tumor cell-intrinsic p38 signaling as a target candidate associated with immune exclusion and reduced immunotherapy response. In human papillomavirus-negative head and neck squamous carcinoma (HNSCC), molecular analysis of 395 tumor tissues revealed a p38-centered network enriched in non-T cell-inflamed tumors. Multi-cancer single-cell RNA sequencing analysis of over 200,000 cells further identifies p38 activation as a potential immune-exclusion program across multiple epithelial tumor types, including HNSCC and lung squamous cell carcinoma (LUSC), supported by tissue validation in [~]250 human biospecimens using multispectral imaging and digital spatial profiling. Functional studies demonstrate that p38 knockdown or pharmacologic inhibition in HNSCC and LUSC cell lines increases T cell migration, with CXCL16 identified as a chemokine mediator in vitro; neutralization of CXCL16 attenuated this effect. Together, these findings identify tumor-intrinsic p38 activation as a driver of immune exclusion in epithelial cancers and support its potential as a therapeutic target to overcome immunotherapy resistance.

Cancer Biology↗